This third of five exclusive episodes explores how clinicians can navigate newly approved MASH therapies -- resmetirom (Rezdiffra) and semaglutide (Wegovy) -- and how to tailor treatment choices based ...
UBS Global Healthcare Conference 2025 November 11, 2025 10:15 AM ESTCompany ParticipantsAlex Thurman - Senior VP ...
UBS Global Healthcare Conference 2025 November 11, 2025 9:30 AM ESTCompany ParticipantsRobert McMahon - Senior ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈